“…Among 13 autoimmune diseases evidence in support of a probable role of HPI was found in four—TP, Graves’ disease, neuromyelitis optica and psoriasis [ 361 ]. Just to mention some examples of contradictory conclusions: many reports and meta-analyses suggested a positive correlation between HPI, metabolic associated fatty liver disease (MAFLD; previous term non-alcoholic fatty liver disease, NAFLD) [ 362 , 363 , 364 , 365 , 366 , 367 , 368 , 369 , 370 , 371 , 372 ], type 2 diabetes mellitus (DM)/insulin resistance [ 373 , 374 , 375 , 376 , 377 ], diabetic complications [ 378 , 379 , 380 ] and obesity [ 381 , 382 ], whereas others did not found such associations [ 383 , 384 , 385 , 386 , 387 , 388 , 389 ] and some described an inverse correlation of HPI with obesity [ 390 , 391 , 392 ]. Similarly, there is discrepancy between various studies regarding links between HPI and cardiovascular diseases (CVD) [ 333 , 393 , 394 , 395 , 396 , 397 , 398 , 399 , 400 ].…”